Vivo Ventures Fund VI, L.P., 10% Owner at Sagent Pharmaceuticals, Inc. (SGNT), sold 696,823 shares at $16.87 ($11.0M) on 2015-11-02, disclosed to the SEC on 2015-11-04.
Open-market sale of $11.0M SGNT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.87 | 680 | $11K | 0.1% |
| 2 | $16.87 | 92,843 | $1.6M | 14.3% |
| 3 | $16.32 | 490 | $8K | 0.1% |
| 4 | $16.32 | 66,793 | $1.1M | 9.9% |
| 5 | $15.45 | 3,898 | $60K | 0.5% |
| 6 | $15.45 | 532,119 |
| $8.2M |
| 75.0% |
| Total | $15.72 avg | 696,823 | $11.0M | 100% |
| Filing → |